News Overview

EBITDA grew up by 43% YoY to touch ₹187 crore in Q4 FY25

They are the generic form of Absorica, a well-known prescription treatment for severe and hard to treat forms of nodular acne that the patient has not responded well to other treatments with.

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

The company’s operating EBITDA stood at ₹6,378 crore. EBITDA margin in the quarter was 14.2%.

Operating margins expanded sharply to 15.2% in the March quarter compared to 12% a year ago

Bharat Elec, HDFC Life hit 52-week high in Nifty.

In the financial year ended 2025, the business added 257 new stores. In the previous comparable period, the business opened 539 stores.

The business reported that the robust bottomline growth was backed by a sharp increase in topline as well as stable operating margins.

The contract is a milestone in the collaboration between Cochin Shipyard and the Indian Navy which is a part of the Defence Ministry's initiative of ‘Make in India.’

Hindustan Copper said that its EBITDA margin expanded by 600 bps on a year-on-year basis to 39.95% in the quarter under review.